Operating profit before deduction of amortization: acumenpharm.com (ABOS)
Acumen Pharmaceuticals (ABOS) is developing an Alzheimer's disease therapy, utilizing synthesis outsourcing to minimize capital expenditures. The operating cash flow confirms the financial dynamics, where the current value equals 0.00. The company focuses on neuron protection within the geriatrics segment to mitigate risks. Anticipation of Phase II trial results serves as the key driver, while R&D costs are already priced in.
Summary analytical data breakdowns for Acumen Pharmaceuticals, Inc. (ABOS)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Acumen Pharmaceuticals|ABOS - Long-Term Debt to Equity|Current Liabilities to Equity Acumen Pharmaceuticals Inc.|ABOS - Company Aggregate Debts|Debt to Net Assets Ratio Acumen Pharmaceuticals|ABOS - Company Long-Term Debts|Company Short-Term Debts Acumen Pharmaceuticals|Intermediate Coverage Ratio acumenpharm.com
- earnings and market multiples details:
ABOS - Company Net Income|Future Profit Acumen Pharmaceuticals|ABOS - P/E Multiple|Forward P/E Multiple acumenpharm.com|ABOS - PEG Multiple|Enterprise Value to EBITDA Ratio Acumen Pharmaceuticals|ABOS - Operating profit EBITDA|Net earnings per one share for the last twelve months Acumen Pharmaceuticals|ABOS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth acumenpharm.com|ABOS - Net earnings per share growth this year|Projected earnings per share increase next year Acumen Pharmaceuticals
Summary company analytics:Acumen Pharmaceuticals, Inc
Acumen Pharmaceuticals (ABOS) maintains a leading position in biochemistry, developing methods to neutralize toxic proteins associated with Alzheimer's disease. By analyzing current EBITDA levels, an investor can identify the daily cash flow from core operations stripped of accounting distortions, which allows for the differentiation of real business growth from speculative market noise and prevents the purchase of the asset at its valuation peak.
Who Acumen Pharmaceuticals competes with
Operating profit EBITDA Biogen Idec BIIB|NBIX - Profit before payment of interest, taxes and amortization|regencellbioscience.com (RGC) - Operating profit before deduction of amortization|AXSM: Operating profit EBITDA|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Operating profit before amortization VKTX (Viking Therapeutics Corp)|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|CPRX (catalystpharma.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY (Harmony Biosciences Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|TRVI: Operating profit EBITDA|praxismedicines.com (PRAX) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|CBLL: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Operating profit before deduction of amortization alector.com ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|Neurogene - Operating profit EBITDA|AC Immune S.A. (ACIU) - Operating profit before deduction of amortization|VYGR: Operating profit EBITDA|Profit before interest, taxes and amortization Neumora Corp (NMRA)|Operating profit before deduction of amortization SCLX|Operating profit EBITDA tevogen.com|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Company profit before taxes, interest and amortization CGTX|Operating profit EBITDA IKT (Inhibikase)|Operating income before deduction of amortization Cassava Pharma (SAVA)|Assertio Therapeutics - Operating profit EBITDA|Coya Therapeutics, Inc. (COYA) - Operating profit before deduction of amortization|VTGN: Operating profit EBITDA|Ovid Therapeutics (OVID) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc|Profit before payment of interest, taxes and amortization ATHE|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Operating income before deduction of amortization pepgen.com|Operating profit EBITDA JUNS (Jupiter Neurosciences)|Operating profit EBITDA Relmada Therapeutics Inc RLMD|Annovis Bio Corp - Operating profit EBITDA|GRCE: Profit before payment of interest, taxes and amortization|Firefly Neuroscience, Inc (AIFF) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NeurAxis Inc - Operating profit before amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|NEUP: Operating profit before deduction of amortization|NERV - Operating profit EBITDA|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Addex - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Profit before interest, taxes and amortization Cyclerion CYCN|Operating profit EBITDA PTIX|Operating profit EBITDA pasitheaclinics.com (KTTA)|Operating profit EBITDA CRGT (Cortigent)|ATXI - Operating profit before deduction of amortization|BCLI: Operating profit before deduction of amortization|CARA - Operating profit EBITDA|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Eliem Therapeutics Inc.|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Longboard LBPH|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|nkgenbiotech.com - Operating profit before amortization|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization TRVN|VIGL: Operating profit EBITDA|anewmeds.com - Income before deduction of interest, taxes and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
